olaratumab  - Removal Estimates

💊 olaratumab 

olaratumab  Dialyzability By Different Modalities

MW: 147241.21
Protein Binding: None%
Vd: 7.7 L/kg

📊 Removal Estimates

Estimates based on drug properties and standard treatment parameters.

🩸

Hemodialysis

6.5 mL/min
Poorly Dialyzable
Minimal removal expected. Half-life: 11 days. No supplementation needed. Despite long half-life, clearance is low due to other factors.
Data Used:
✅ molar_mass, mw_factor, vd, vd_factor, half_life
⚠️ Missing: protein_binding
Free fraction: 0.5 Mw factor: 0.2 Vd factor: 0.2 Hl factor: 1.2 Half life: 11 days Half life category: Extended (> 72h)
🫀

Peritoneal Dialysis

0.2 mL/min
Low PD Clearance
Minimal removal expected. No supplementation needed. Half-life: 11 days.
Data Used:
✅ molar_mass, half_life
⚠️ Missing: protein_binding
Free fraction: 0.5 Half life: 11 days Half life category: Extended (> 72h)
🔄

Plasmapheresis (TPE)

Unable to Assess
Insufficient data for TPE risk assessment. Protein binding and Vd required.
Data Used:
✅ vd, half_life
⚠️ Missing: protein_binding
Half life: 11 days Half life category: Extended (> 72h)
🧪

Hemoadsorption

Low Effectiveness
Poor candidate for hemoperfusion. Drug is distributed in tissues. Despite long half-life, large Vd prevents significant removal.
Data Used:
✅ vd, half_life
Half life: 11 days Half life category: Extended (> 72h)

📋 Summary of Estimates

Modality Clearance/Value Half-Life Classification Data Quality
Hemodialysis 6.5 mL/min 11 days Poorly Dialyzable Partial Data
Peritoneal Dialysis 0.2 mL/min 11 days Low PD Clearance Partial Data
Plasmapheresis (TPE) Unable to Assess 11 days N/A Partial Data
Hemoadsorption Low Effectiveness 11 days N/A Complete Data

📌 Important Notes

Back to Drug Details